T1	Participants 141 192	subgroups with glucocorticoid-induced osteoporosis.
T2	Participants 305 366	different subgroups with glucocorticoid-induced osteoporosis.
T3	Participants 580 607	patients on glucocorticoids
T4	Participants 744 771	different patient subgroups
T5	Participants 869 877	Patients
T6	Participants 1065 1294	subpopulations]were subgrouped by age; gender; menopausal status in women; dose and duration of prednisone during the trial; and baseline serum 25-OH vitamin D, LS BMD T-score, creatinine clearance, and concomitant medication use
T7	Participants 1873 1877	BMD.
T8	Participants 1878 1899	Osteoporotic patients
